Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
02/28/2002 | WO2002016647A1 Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization |
02/28/2002 | WO2002016384A2 Apparatus and methods for the automated synthesis of oligosaccharides |
02/28/2002 | WO2002016381A2 Composition and method for inhibiting platelet aggregation |
02/28/2002 | WO2002016375A1 Novel amidite derivatives for synthesising polymers on surfaces |
02/28/2002 | WO2002016023A2 Method and apparatus for in situ synthesis on a solid support |
02/28/2002 | WO2002016022A2 Novel strategie for synthesising polymers on surfaces |
02/28/2002 | WO2001071732B1 Porous ferro- or ferrimagnetic glass particles for isolating molecules |
02/28/2002 | US20020026046 Mixing composition with reducing agent, heating; wherein any ribonucleases in composition are substantially inactivated or inhibited |
02/28/2002 | US20020026044 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
02/28/2002 | US20020025572 Separating nucleotide sequences in sample; obtain sample, extract nucleotide sequences, incubate sample with nucleotide sequence carrier, separate bound nucleotide sequences, dissociate nucleotide sequences, recover nucleotide sequences |
02/28/2002 | US20020025528 Use of genetic markers to diagnose familial dysautonomia |
02/28/2002 | US20020025305 Cell-cycle regulatory proteins, and uses related thereto |
02/28/2002 | CA2420179A1 Composition and method for inhibiting platelet aggregation |
02/28/2002 | CA2418127A1 Transgenic plants with enhanced phenotypic properties and methods for producing them |
02/28/2002 | CA2386913A1 Methods for external controls for nucleic acid amplification |
02/27/2002 | EP1182206A2 Stabilized oligonucleotids and the use thereof |
02/27/2002 | EP1181390A1 27 human secreted proteins |
02/27/2002 | EP1181335A1 Extended rhodamine compounds useful as fluorescent labels |
02/27/2002 | EP1181304A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin |
02/27/2002 | EP1181301A1 Oligonucleotide synthesis with lewis acids as activators |
02/27/2002 | EP1130117A9 Method and device for detection of nucleic acid using total internal reflectance |
02/27/2002 | EP1130116A9 Method and device for detection of nucleic acid using total internal reflectance |
02/27/2002 | EP1100809A4 Rna targeted 2'-modified oligonucleotides that are conformationally preorganized |
02/27/2002 | EP0536330B1 Glyphosate tolerant plants |
02/27/2002 | CN1079832C Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell |
02/27/2002 | CN1079830C Methods and materials for treatment of individuals infected with intracellular infections agents |
02/26/2002 | US6350863 3, 4-di(acylamino)phenyl ribofuranosides, 2'-deoxyribofuranosides, and methods of making |
02/26/2002 | US6350853 Conjugated peptide nucleic acids having enhanced cellular uptake |
02/26/2002 | US6350595 Utilizing alternating presynthesized mononucleotide and presynthesized dinucleotide as monomeric synthesis unit, carrying out synthesis on support |
02/26/2002 | US6350592 Aortic-specific enhancer sequence and uses thereof |
02/26/2002 | CA2072484C Use of nadh or nadph against cancer and aids |
02/21/2002 | WO2002014867A2 Ultra-sensitive detection systems |
02/21/2002 | WO2002014558A2 New hydrazide building blocks and hydrazide modified biomolecules |
02/21/2002 | WO2002014555A2 Single-labeled oligonucleotide probes |
02/21/2002 | WO2002014545A2 Method for determining weather a test compound binds to a large rna target |
02/21/2002 | WO2002014340A1 Processes for the preparation of oligonucleotides_______________ |
02/21/2002 | WO2001081608A3 Viral vectors for use in monitoring hiv drug resistance |
02/21/2002 | WO2001060856A3 Vmglom gene and its mutations causing disorders with a vascular component |
02/21/2002 | WO2001057264A3 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes |
02/21/2002 | WO2001018524A3 Methods for improving signal detection from an array |
02/21/2002 | US20020022721 Methods of array synthesis |
02/21/2002 | US20020022033 Diagnosis of Aids |
02/21/2002 | US20020022001 Nucleosides for imaging and treatment applications |
02/21/2002 | CA2419159A1 Ultra-sensitive detection systems |
02/21/2002 | CA2417986A1 Single-labeled oligonucleotide probes |
02/20/2002 | EP1180113A1 Oligonucleotides having a-dna form and b-dna form conformational geometry |
02/20/2002 | EP1180112A1 Detection using degradation of a tagged sequence |
02/20/2002 | EP1180111A1 Method and apparatus for compound library preparation using optical modulator |
02/20/2002 | EP0749485B1 Antimicrobial proteins from impatiens |
02/19/2002 | US6348596 Non-fluorescent asymmetric cyanine dye compounds useful for quenching reporter dyes |
02/19/2002 | US6348589 Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
02/19/2002 | US6348588 Method of cleaving a nucleic acid bulge |
02/19/2002 | US6348583 Nucleobase containing polythioethers synthesized on polyethylene glycol, succinic anhydride and propylamine modified glass; nucleic acid mimetics |
02/19/2002 | US6348312 Oligonucleotide having length of 6-100 nucleotides, wherein at least one non-terminal pyrimidine nucleoside is modified, and also 5' and/or 3' ends are modified, by replacement of 3' and/or 5' phosphodiester bridge by phosphorothioate bridge |
02/19/2002 | CA2141060C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods |
02/14/2002 | WO2002012902A2 Split-ubiquitin based reporter systems and methods of their use |
02/14/2002 | WO2002012567A1 Vhl promoter diagnostic polymorphism |
02/14/2002 | WO2002012566A2 The use and evaluation of a [2+2] photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix |
02/14/2002 | WO2002012565A1 Association of sim2 with cancer |
02/14/2002 | WO2002012263A1 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses |
02/14/2002 | WO2001075139A8 Reversible chemical modification of nucleic acids and improved method for nucleic acid hybridization |
02/14/2002 | WO2001059093A3 Full-length infectious cdna clones of tick borne flavivirus |
02/14/2002 | WO2001036439A3 Method for constructing oligodesoxyribonucleotide binomial libraries with codon mutagenized using desoxynucleoside-phosphoramitides |
02/14/2002 | US20020019481 Non-luminescent substrate |
02/14/2002 | US20020019359 Oligonucleotide with a base sequence complementary to a target portion of a nucleic acid encoding angiogenin |
02/14/2002 | DE10038237A1 Verfahren zum Nachweis von Mutationen in Nucleotidsequenzen A method for detecting mutations in nucleotide sequences |
02/14/2002 | CA2569615A1 Nucleic acid binding compounds containing pyrazolo[3,4-d] pyrimidine analogues of purin-2,6-diamine and their uses |
02/14/2002 | CA2453907A1 Association of sim2 with cancer |
02/14/2002 | CA2418094A1 Vhl promoter diagnostic polymorphism |
02/14/2002 | CA2417888A1 Split-ubiquitin based reporter systems and methods of their use |
02/13/2002 | EP1179350A2 Encapsulated cell system for implantation into the human CNS |
02/13/2002 | EP1179057A2 pH DEPENDENT ION EXCHANGE MATRIX AND METHOD OF USE IN THE ISOLATION OF NUCLEIC ACIDS |
02/13/2002 | EP1179028A1 Solvent resistant photosensitive compositions |
02/13/2002 | EP1179003A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene |
02/13/2002 | EP1179000A2 Secreted proteins and uses thereof |
02/13/2002 | EP1178999A2 L-ribo-lna analogues |
02/13/2002 | EP1178722A1 eNOS MUTATIONS USEFUL FOR GENE THERAPY AND THERAPEUTIC SCREENING |
02/13/2002 | EP0912470B1 Method and device for purifying and enriching molecules |
02/13/2002 | EP0866878A4 Detection of mammary tumor virus-like sequences in human breast cancer |
02/13/2002 | CN1335936A Coupling of lipopolysaccharide-derived carbohydrates onto solid surfaces |
02/12/2002 | US6346655 Trichothecne-Resistant transgenic plants |
02/12/2002 | US6346614 Hybrid oligonucleotide phosphorothioates |
02/12/2002 | US6346613 An antisense oligonucleotide that hybridizes with a occludin mrna and disrupts tight junctions, to increase cell layer permeability to solutes and drugs |
02/12/2002 | US6346611 High affinity TGfβ nucleic acid ligands and inhibitors |
02/12/2002 | US6346510 Antiproliferative, anticarcinogenic and antitumor agents |
02/12/2002 | US6346423 Methods and compositions for producing biopolymeric arrays |
02/12/2002 | US6346416 Antisense inhibition of HPK/GCK-like kinase expression |
02/12/2002 | US6346413 Polymer arrays |
02/12/2002 | US6346407 Xylanase, microorganisms producing it, DNA molecules, methods for preparing this xylanase and uses of the latter |
02/12/2002 | US6346398 Ribozyme or antisense nucleic acid which inhibits synthesis, gene expression and/or stability of messenger rna encoding the flt-1 receptor of human or mouse receptor; treatment of diabetic retinopathy; angiogenesis inhibitors |
02/12/2002 | US6346394 Dna having specific nucleotide sequence; for recombinant production of enzyme and high yield, industrial scale production of trehalose |
02/12/2002 | US6346387 Detection of binding reactions using labels detected by mediated catalytic electrochemistry |
02/12/2002 | US6346378 Nucleic acid analogs with a chelating functionality |
02/12/2002 | US6346246 Antibodies that bind human haemopoietic maturation factor |
02/12/2002 | CA2131837C High molecular weight surface proteins of non-typeable haemophilus |
02/07/2002 | WO2002010758A2 Surface-attached polyfunctional polymer networks for sensor chips |
02/07/2002 | WO2002010458A2 Method of performing subtractive hybridization |
02/07/2002 | WO2002010455A2 Methods for identifying genomic deletions |
02/07/2002 | WO2002010449A2 Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome |
02/07/2002 | WO2002010432A2 Triphosphate oligonucleotide modification reagents and uses thereof |